How will the SMART trial results impact our practice and decision making in TAVI? - EuroPCR скачать в хорошем качестве

How will the SMART trial results impact our practice and decision making in TAVI? - EuroPCR

Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women. At one year, clinical outcomes were identical, but valve haemodynamics differed. They explain the methodology, the choice of BARC 2 over BARC 3, and the implications for clinical practice and transcatheter valve replacement decision-making. They also address the higher incidence of paravalvular leak in the balloon-expandable valve and conclude by discussing annular rupture. Sponsored by Medtronic This video was filmed during #EuroPCR 2024. See more videos here: https://www.pcronline.com/Cases-resou... #tavi #smallannulus #paravalvularleak #selfexpandablevalve #balloonexpandablevalve